Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab
JAMA Oncology - United States
doi 10.1001/jamaoncol.2019.2187
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2019
Authors
Publisher
American Medical Association (AMA)